Wednesday, June 6, 2007

Risks of Glaxo diabetes drug still unclear: FDA

(Reuters) - At a House of Representatives committee hearing, Democrats asked why the FDA had failed to request a study years ago that would have shed more light on Avandia's effect on the heart.




Republicans, meanwhile, said the spotlight on the drug was political rather than scientific.


Read more at Reuters.com Business News

No comments: